ITGAX and non-small cell lung carcinoma: Like the A549 NSCLC lung metastasis model, the antitumor effect of NPRL2 was correlated with the presence of innate immune cells including HLA-DR+ DC and CD11c+ DC, and adaptive immune cells including TILs and NK cells in the TME.